Congenital heart defects (CHDs) are anomalies in the heart's structure present at birth, impacting its form and function. These defects originate during fetal development, affecting components like heart valves, walls, arteries, or veins. The severity of CHDs varies, ranging from minor issues to potentially life-threatening complications. While the exact causes of most congenital heart defects remain elusive, factors such as genetic predisposition, maternal health, and environmental influences are believed to play a role. The symptoms and implications of CHDs may surface at different life stages, underscoring the importance of early detection and timely intervention. The management of congenital heart defects has witnessed remarkable progress due to advances in medical technology and surgical techniques. These developments have significantly enhanced the prognosis for individuals with CHDs, enabling many to lead fulfilling and relatively normal lives with appropriate medical care and support. Nonetheless, ongoing research efforts are essential to deepen our understanding of the intricacies surrounding congenital heart defects.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States